Maki Nakazawa

Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study

Koichi Miyata, Tetsuji Kaneko, Yoshihiko Morikawa et al. · The Lancet Child & Adolescent Health · 2018 · 101 citations

Life Sciences, Immunology, Pharmacology +7

Gene Knock-Outs of Inositol 1,4,5-Trisphosphate Receptors Types 1 and 2 Result in Perturbation of Cardiogenesis

Keiko Uchida, Megumi Aramaki, Maki Nakazawa et al. · PLoS ONE · 2010 · 79 citations · Full text

Life Sciences, Molecular Biology, Physiology +17

Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease

Koichi Miyata, Masaru Miura, Tetsuji Kaneko et al. · Circulation Cardiovascular Quality and Outcomes · 2021 · 35 citations

Medicine, Immunology, Internal Medicine +12

Inositol 1,4,5-trisphosphate receptors are essential for the development of the second heart field

Maki Nakazawa, Keiko Uchida, Megumi Aramaki et al. · Journal of Molecular and Cellular Cardiology · 2011 · 34 citations

Life Sciences, Cardiology, Physiology +14

Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A₂ and prostacyclin

Hiroyuki Fukushima, Kenjiro Kosaki, Reiko Sato et al. · American Journal of Medical Genetics Part A · 2010 · 33 citations

Medicine, Cardiology, Pediatrics +12